Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome
Authors:
- Noora RistiniemiNRNoora Ristiniemi
- Juha LundJLJuha Lund
- Risto TerttiRTRisto Tertti
- Anders ChristenssonACAnders Christensson
- Tuomo IlvaTITuomo Ilva
- Pekka PorelaPPPekka Porela
- Kari PulkkiKPKari Pulkki
- Kim PetterssonKPKim Pettersson
- 1 May 2012
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 45 (7-8) , 535-540
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal functionNephrology Dialysis Transplantation, 2011
- Cystatin C Identifies Chronic Kidney Disease Patients at Higher Risk for ComplicationsJournal of the American Society of Nephrology, 2011
- Estimation of the Age-Dependent Decline of Glomerular Filtration Rate from Formulas Based on Creatinine and Cystatin C in the General Elderly PopulationNephron Clinical Practice, 2010
- Method of Glomerular Filtration Rate Estimation Affects Prediction of Mortality RiskJournal of the American Society of Nephrology, 2009
- Rate of Kidney Function Decline in Older Adults: A Comparison Using Creatinine and Cystatin CAmerican Journal of Nephrology, 2009
- StAR: a simple tool for the statistical comparison of ROC curvesBMC Bioinformatics, 2008
- Cystatin C and Estimates of Renal Function: Searching for a Better Measure of Kidney Function in Diabetic PatientsClinical Chemistry, 2007
- Biomarkers of inflammation and progression of chronickidney diseaseKidney International, 2005
- Comparison of Cardiac Troponin I Immunoassays Variably Affected by Circulating AutoantibodiesClinical Chemistry, 2005
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976